BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Batra S, Conklin LS. Therapeutics for Inflammatory Bowel Diseases in Children and Adolescents: A Focus on Biologics and an Individualized Treatment Paradigm. Handb Exp Pharmacol 2020;261:363-75. [PMID: 31342277 DOI: 10.1007/164_2019_255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Matar M, Shamir R, Lev-zion R, Broide E, Weiss B, Ledder O, Guz-mark A, Rinawi F, Cohen S, Topf-olivestone C, Shaoul R, Yerushalmi B, Assa A. The Effect of Adalimumab Treatment on Linear Growth in Children With Crohn Disease: A Post-hoc Analysis of the PAILOT Randomized Control Trial. Journal of Pediatric Gastroenterology & Nutrition 2020;71:237-42. [DOI: 10.1097/mpg.0000000000002728] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kim MJ, Kim E, Kang B, Choe YH. Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease. J Pediatr Gastroenterol Nutr 2021;72:870-6. [PMID: 33908743 DOI: 10.1097/MPG.0000000000003070] [Reference Citation Analysis]